KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Health Services (UHS) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Universal Health Services (UHS) over the last 17 years, with Q3 2025 value amounting to $112.9 million.

  • Universal Health Services' Cash & Equivalents rose 642.74% to $112.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.9 million, marking a year-over-year increase of 642.74%. This contributed to the annual value of $126.0 million for FY2024, which is 547.89% up from last year.
  • According to the latest figures from Q3 2025, Universal Health Services' Cash & Equivalents is $112.9 million, which was up 642.74% from $137.6 million recorded in Q2 2025.
  • Universal Health Services' Cash & Equivalents' 5-year high stood at $764.5 million during Q1 2021, with a 5-year trough of $74.6 million in Q3 2022.
  • Over the past 5 years, Universal Health Services' median Cash & Equivalents value was $115.3 million (recorded in 2021), while the average stood at $153.9 million.
  • Over the last 5 years, Universal Health Services' Cash & Equivalents had its largest YoY gain of 129969.97% in 2021, and its largest YoY loss of 9058.38% in 2021.
  • Universal Health Services' Cash & Equivalents (Quarter) stood at $115.3 million in 2021, then fell by 10.83% to $102.8 million in 2022, then increased by 16.17% to $119.4 million in 2023, then increased by 5.48% to $126.0 million in 2024, then decreased by 10.39% to $112.9 million in 2025.
  • Its Cash & Equivalents was $112.9 million in Q3 2025, compared to $137.6 million in Q2 2025 and $126.8 million in Q1 2025.